Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2006

FR Doc E6-9504 [Federal Register: June 19, 2006 (Volume 71, Number 117)] [Notices] [Page 35311] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr19jn06-88]


Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated January 11, 2006, and published in the Federal Register on January 23, 2006 (71 FR 3543), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:

Drug Schedule
Cathinone (1235)  I
Methcathinone (1237)  I
N-Ethylamphetamine (1475)  I
N,N-Dimethylamphetamine (1480)  I
Aminorex (1585)  I
4-Methylaminorex (cis isomer) (1590)  I
Gamma Hydroxybutyric acid (2010)  I
Methaqualone (2565)  I
Alpha-Ethyltryptamine (7249)  I
Lysergic acid diethylamide (7315)  I
Marihuana (7360)  I
Tetrahydrocannabinols (7370)  I
Mescaline (7381)  I
3,4,5-Trimethoxyamphetamine (7390)  I
4-Bromo-2,5-dimethoxyamphetamine (7391)  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)  I
4-Methyl-2,5-dimethoxyamphetamine (7395)  I
2,5-Dimethoxyamphetamine (7396)  I
2,5-Dimethoxy-4-ethylamphetamine (7399)  I
3,4-Methylenedioxyamphetamine (7400)  I
5-Methoxy-3,4-methylenedioxyamphetamine (7401)  I
N-Hydroxy-3,4-methylendioxyamphetamine (7402)  I
3,4-Methylendioxy-N-ethylamphetamine (7404)   I
3,4-Methylenedioxymethamphetamine (7405)  I
4-Methoxyamphetamine (7411)  I
Bufotenine (7433)  I
Diethyltryptamine (7434)  I
Dimethyltryptamine (7435)  I
Psilocybin (7437)  I
Psilocyn (7438)  I
Acetyldihydrocodeine (9051)  I
Benzylmorphine (9052)  I
Codeine-N-oxide (9053)  I
Dihydromorphine (9145)  I
Heroin (9200)  I
Hydromorphinol (9301)  I
Methyldihydromorphine (9304)  I
Morphine-N-oxide (9307)  I
Normorphine (9313)  I
Pholcodine (9314)  I
Acetylmethadol (9601)  I
Allylprodine (9602)  I
Alphacetylmethadol except levo-alphacetylmethadol (9603)  I
Alphameprodine (9604)  I
Alphamethadol (9605)  I
Betacetylmethadol (9607)  I
Betameprodine (9608)  I
Betamethadol (9609)  I
Betaprodine (9611)  I
Hydroxypethidine (9627)  I
Noracymethadol (9633)  I
Norlevorphanol (9634)  I
Normethadone (9635)  I
Trimeperidine (9646)  I
Phenomorphan (9647)  I
Para-Fluorofentanyl (9812)  I
3-Methylfentanyl (9813)  I
Alpha-Methylfentanyl (9814)  I
Acetyl-alpha-methylfentanyl (9815)  I
Beta-hydroxyfentanyl (9830)  I
Beta-hydroxy-3-methylfentanyl (9831)  I
Alpha-Methylthiofentanyl (9832)  I
3-Methylthiofentanyl (9833)  I
Thiofentanyl (9835)  I
Amphetamine (1100)  II
Methamphetamine (1105)  II
Phenmetrazine (1631)  II
Methylphenidate (1724)  II
Amobarbital (2125)  II
Pentobarbital (2270)  II
Secobarbital (2315)  II
Glutethimide (2550)  II
Nabilone (7379)  II
1-Phenylcyclohexylamine (7460)  II
Phencyclidine (7471)  II
1-Piperidinocyclohexanecarbonitrile (8603)  II
Alphaprodine (9010)  II
Cocaine (9041)  II
Codeine (9050)  II
Dihydrocodeine (9120)  II
Oxycodone (9143)  II
Hydromorphone (9150)  II
Diphenoxylate (9170)  II
Benzoylecgonine (9180)  II
Ethylmorphine (9190)  II
Hydrocodone (9193)  II
Levomethorphan (9210)  II
Levorphanol (9220)  II
Isomethadone (9226)  II
Meperidine (9230)  II
Methadone (9250)  II
Methadone intermediate (9254)  II
Dextropropoxyphene, bulk (non-dosage forms) (9273)  II
Morphine (9300)  II
Thebaine (9333)  II
Levo-alphacetylmethadol (9648)  II
Oxymorphone (9652)  II
Noroxymorphone (9668)  II
Racemethorphan (9732)  II
Alfentanil (9737)  II
Sufentanil (9740)  II
Fentanyl (9801)  II

The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cerilliant Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: June 12, 2006.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. E6-9504 Filed 6-16-06; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility